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Functional foods can be defined as foods and food com-
ponents that provide a health benefit beyond basic nutrition.
This new edition of the Handbook of Nutraceutical and Func-
tional Foods covers more than 200 nutraceutical compounds
and presents a recent and comprehensive review of the growing
field of nutritional science.
The book comprises 28 chapters contributed by international
experts. It is very neatly presented and contains some useful
tables and numerous figures illustrating chemical structures and
metabolic pathways. The first chapter provides a general
overview of the history of research on nutraceuticals and
functional foods and serves as an introduction to the topic as a
whole. Other chapters in the book cover the major topics related
to foods that have nutritional benefits for improving health and
reviews information on chemical properties, biochemical
activity, dietary sources, and findings for the compounds
discussed. Some of the foodstuffs reviewed include garlic,
grape wine, tea, omega-3 fish oils, pepper fruits, olive oil and
coffee. There is substantial information on compounds such as
isoflavones, lycopene, polyphenols, dietary fibre, omega-3 fatty
acids, conjugated linoleic acids, tocopherols and coenzyme Q-
10, and the role of probiotics and prebiotics are also discussed.
Various medical conditions and ailments are dealt with
including several types of cancer, atherosclerosis and coronary
heart disease, osteoarthritis, rheumatoid arthritis, osteoporosis,
diabetes, depression, inflammation, obesity and non-alcoholic
steatohepatitis. Other topics such as the shelf life of nutraceu-
ticals and marketing and regulatory issues are also considered,
and attention is given to policies dealing with the alleviation of
obesity.
Revised and updated from the first edition published in 2001,
new topics include the use of exopolysaccharides from lactic acid
bacteria, nutraceuticals to be used in the adjunctive treatment of
depression, and protein as a functional ingredient for weight loss.
Additional new chapters review recent studies on nutraceuticals
and inflammation in athletes, oxidative stress and antioxidant
requirements in athletes, and nutrition and lifestyle interventions
for osteoarthritis management. Each chapter in the book carefully
examines the relevant scientific literature in a logical manner, and
presents scientific backing for recommendations on “what to eat”
and the health benefits of certain foods. Information and data is
provided that would be of value to food scientists, nutritionists,
students and researchers in the field. The extensive reference lists
at the end of each chapter also serve as a valuable reference source.
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Prior to the implementation of governmental regulations for
genetic engineering, scientists who actively developed the new
molecular tools which lead to the production of genetically
modified organisms, had established voluntary guidelines for
governing molecular biology. Letters by prominent scientists
calling for a moratorium, even on their own laboratory experi-
ments, stated that their respective governments have to regulate
this new field before the new technology becomes part of daily
practice. Scientists gathered in Asilomar in the mid-seventies and
signed a letter, published in Science, on themajor objectives of the
regulatory rules for biotechnology. The first such guideline re-
leased by the National Institute of Health was very strict. The
document was followed by other regulations in different coun-
tries, including a Recombinant DNA safety consideration, com-
piled by OECD member state experts in 1986. In the European
Union directives were issued in 1990 on the release and use of
genetically modified organisms. Almost all international organi-
zations included in their portfolios geneticallymodified organisms
as an important issue, realizing their potential economic, health
and environmental benefits. Recently the Convention on
Biological Diversity issued the Cartagena protocol, a legally
binding document on the transboundary movement of living
modified organisms. All of the above mentioned activities were
